Status: current, Defined. Date: 31-Mar 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3729641000168112 | Irbesartan/HCT 300/12.5 (Sandoz) (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3729651000168114 | Irbesartan/HCT 300/12.5 (Sandoz) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 538069058 | |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | Is a | Irbesartan/HCT 300/12.5 (Sandoz) | true | Inferred relationship | Some | ||
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | Is a | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 538069058 | |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has intended active ingredient | irbesartan | true | Inferred relationship | Some | 1426651476 | |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1426651477 | |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet | has Australian BoSS | irbesartan | true | Inferred relationship | Some | 1426651476 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet, 30 | has TPUU | True | Irbesartan/HCT 300/12.5 (Sandoz) tablet | Inferred relationship | Some | 1 |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet, 30, blister pack | has TPUU | True | Irbesartan/HCT 300/12.5 (Sandoz) tablet | Inferred relationship | Some | 1 |
| Irbesartan/HCT 300/12.5 (Sandoz) tablet, 30, bottle | has TPUU | True | Irbesartan/HCT 300/12.5 (Sandoz) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR